Develops small-molecule therapeutics using AI-driven platform that combines physics-based algorithms with experimental testing
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Entos is a biotechnology company that utilizes an AI-driven platform to tackle complex challenges in drug discovery. By integrating physics-based AI algorithms with high-throughput experimentation, the company rapidly designs and optimizes small-molecule therapeutics across various disease areas. Their approach enables the exploration of multiple target profiles simultaneously, leading to the development of differentiated clinical candidates at an accelerated pace.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Entos Management Team
Entos Valuations & Financials
View real-time NPM data on Entos stock including daily Entos stock price estimates, valuation history, and historical share price information. Access Entos financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Entos pricing across six independent market signals. Looking for private company due diligence data sources on Entos? Get in touch to learn more.
Similar Companies
like Entos
Mitra Bio
Healthcare & Life Sciences
Offers non-invasive skin diagnostics analyzing DNA methylation to assess skin health and aging.
Alessa Therapeutics
Healthcare & Life Sciences
Develops implantable drug-delivery systems that release targeted anti-androgen therapies to improve precision and minimize side effects.
Abpro
Healthcare & Life Sciences
Develops advanced biomedical engineering solutions, combining robotics and AI to enhance medical equipment and improve healthcare treatments.
FastWave Medical
Healthcare & Life Sciences
Develops intravascular lithotripsy systems for calcific artery disease, focusing on procedural efficiency and improved patient care.
Sequencing.com
Healthcare & Life Sciences
Empowers users to analyze and interpret genetic data using tools that convert DNA information into actionable health insights.
Calviri
Healthcare & Life Sciences
Provides multi‑cancer early detection and low‑cost vaccines to prevent or treat tumors.
Bloomer Tech
Healthcare & Life Sciences
Creates wearable health tech that captures real‑time cardiovascular data from advanced sensors to support personalized heart health monitoring.
Formation Bio
Healthcare & Life Sciences
Acquires clinical-stage assets and accelerates their development with tech-driven trial design and execution.
Switchback Systems
Healthcare & Life Sciences
Delivering plug-and-play benchtop DNA synthesis and assembly for rapid, lab-based gene construction with efficiency and precision.
FAQ
We have answers
Entos stock does not trade on public stock exchanges. Entos stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Entos stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Entos Stock does not trade on public stock exchanges. In order to sell Entos shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Entos does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Entos share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Entos stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Entos stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Entos stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Entos is a private company and has not had an IPO. There is currently no Entos IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Entos IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
